首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Parkinsons disease

缩写:PARKINSONS DIS-US

ISSN:2090-8083

e-ISSN:2042-0080

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引198
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Stefanie D Vassar,Yvette M Bordelon,Ron D Hays et al. Stefanie D Vassar et al.
The motor examination section of the unified Parkinson's disease rating scale (UPDRS) is widely used in research but few studies have examined whether subscales exist that tap relatively distinct motor abnormalities. We analyzed data from 1...
J Guridi,R González-Redondo,J A Obeso J Guridi
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson's disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced ...
Ana María Sánchez-Pérez,Berta Claramonte-Clausell,Juan Vicente Sánchez-Andrés et al. Ana María Sánchez-Pérez et al.
It is generally accepted that a correlation between neurodegenerative disease and protein aggregation in the brain exists; however, a causal relationship has not been elucidated. In neurons, failure of autophagy may result in the accumulati...
Prashanth Chandramani Shivalingappa,Huajun Jin,Vellareddy Anantharam et al. Prashanth Chandramani Shivalingappa et al.
Methamphetamine- (MA-) induced neurotoxicity is associated with mitochondrial dysfunction and enhanced oxidative stress. Our previous study demonstrated that MA induces autophagy in a dopaminergic neuronal cell model (N27 cells). The cellul...
Ferdinando Nicoletti,Ingrid Philippens,Paolo Fagone et al. Ferdinando Nicoletti et al.
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) is a synthetic androstenetriol in Phase II clinical development for the treatment of inflammatory diseases. HE3286 was evaluated for blood-brain barrier (BBB) permeability in mice, and ...
Iracema Leroi,Hiranmayi Pantula,Kathryn McDonald et al. Iracema Leroi et al.
Neuropsychiatric symptoms commonly complicate Parkinson's disease (PD), however the presence of such symptoms in mild cognitive impairment (PD-MCI) specifically has not yet been well described. The objective of this study was to examine and...
José M Bravo-San Pedro,Rubén Gómez-Sánchez,Elisa Pizarro-Estrella et al. José M Bravo-San Pedro et al.
Parkinson's disease is the second common neurodegenerative disorder, after Alzheimer's disease. It is a clinical syndrome characterized by loss of dopamine-generating cells in the substancia nigra, a region of the midbrain. The etiology of ...
Patricia Muñoz,Sandro Huenchuguala,Irmgard Paris et al. Patricia Muñoz et al.
The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α-synuclein aggregation, oxidative stress, neuroinflammation,...